Concepedia

Yongfang Ma

YM

19

Publications

506

Citations

14

H-Index

2019

Active since

Affiliations

Anhui University of Science and Technology(Current)

Zhejiang University

Jinan University

Sichuan University

Zhejiang Environmental Monitoring Center

Yongfang Ma is an author at Anhui University of Science and Technology specializing in medicine, cell biology, and cancer biology.

ORCID

Top concepts

Publications per year

2019–2024

19

Publications

19

miR-410 induces both epithelial–mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer

Yuan Yue, Hu Liao, Qiang Pu et al. · Signal Transduction and Targeted Therapy · 2020 · 85 citations · Full text

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li et al. · PubMed · 2019 · 44 citations · Full text

, , +17

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li et al. · Toxicology Mechanisms and Methods · 2021 · 40 citations

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Yongfang Ma, Ruyue Xu, Xueke Liu et al. · International Journal of Medical Sciences · 2021 · 36 citations · Full text

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li, Rongbo Zhang, Yinci Zhang et al. · PubMed · 2019 · 32 citations · Full text

Rows per page

1–5 of 19